After months of hard work in the laboratories of Pfizer and BioNTech, the innovative coronavirus vaccine is ready to be thrown into battle, as the British authorities have given their approval to start the vaccinations from next week, a move which, however provoked reactions in the rest of Europe. For
Britain is coming out of a four-week lockdown today and returning to a three-tier system of restrictions to curb the spread of the coronavirus, with British Prime Minister Boris Johnson hoping to lift the restrictions in the spring thanks to vaccine launches. -19 and a campaign to conduct mass diagnostic
New Covid-19 infections fell by about 30% in the UK after almost three weeks of restrictive measures (national lockdown). For the first time since August, the reproductive R index, that is, the transmission of the virus from one vector to other humans, fell below one (1), to about 0.9%, as
Vaccines against COVID-19 will be given priority to people in Britain depending on the risk they run, but operational practical issues may affect who gets it first, said the chairman of Britain’s Joint Vaccination and Immunization Committee. The highest priority will be given to tenants and nursing home staff, followed
Vaccinations in the United Kingdom begin next week Britain is the first country to approve the coronavirus vaccine for use by Pfizer and BioNTech, starting next week. “The government has accepted the recommendation of the Independent Drugs and Health Products Regulatory Authority (MHRA) to approve the Pfizer / BioNTech vaccine
Noting that the UK economy has been hit hardest by most of the advanced countries by the coronavirus pandemic, the debate could not be more intense than it is today, given the final phase of the Brexit negotiations. The country’s GDP may turn out to be lower than it would